Jan. 26, 2024
by Natalia Honchar
Biopharma insight
When we hear “AI in drug discovery”, there is a high chance our imagination would draw a small molecule discovery …
Jan. 26, 2024
by Andrii Buvailo, PhD
Biopharma insight
The year 2024 has ushered in a new wave of excitement in the biotech industry, with several promising companies making …
Jan. 25, 2024
by Dana Sokolova, Andrii Buvailo
Biopharma insight
Nearly two decades ago, a groundbreaking discovery in the field of biomedical research emerged, known as organ-on-a-chip technology, which quickly …
Jan. 25, 2024
by Andrii Buvailo
Biopharma insight
In the early 2000s, the concept of organ-on-a-chip technology, also known as microphysiological systems, emerged as a way to replicate …
Jan. 24, 2024
by Andrii Buvailo
Biopharma insight
According to a 2023 Deloitte report, "Sizing the Brain," by Álvaro Nuño Pérez, Jose M Suárez, and Michel LE BARS, providing an in-depth analysis of …
Jan. 12, 2024
by Dana Sokolova
Biopharma insight
In 2023, the venture capital (VC) landscape witnessed significant activity, providing crucial support to the biotech sector amidst a volatile …
Jan. 11, 2024
by Michael Whitworth, Trevor Hutchings, Alex Jones
Biopharma insight
Healthcare is one of the cornerstones of our society. High-quality healthcare is effective, patient-centric and vital for the population's well-being. …
Jan. 11, 2024
by Andrii Buvailo
Interview
Tackling production inefficiencies, faulty products, and costly machine maintenance are just a few of the many issues that are hardly …
Jan. 9, 2024
by Andrii Buvailo
Biopharma insight
In a notable advancement for the fast-moving consumer goods (FMCG) industry, Spore.Bio, a deeptech startup, has recently raised €8 million in …
Jan. 7, 2024
by Dana Sokolova
Biopharma insight
With over half of the world's population being female, it's only natural that the world of femtech is experiencing a …
Jan. 5, 2024
by Irina Bilous, Andrii Buvailo
Biopharma insight
The clinical trial is a critical stage of drug development workflow, with an estimated average success rate of about 11% …
Dec. 27, 2023
by Andrii Buvailo
Biopharma insight
The biopharma industry experienced a challenging year in 2023, marked by a significant decrease in funding and a high number …